Surgery

Acute pancreatitis in COVID-19 patients: true risk?
Bulthuis, M. C., Boxhoorn, L., Beudel, M., Elbers, P. W. G., Kop, M. P. M., van Wanrooij, R. L. J., Besselink, M. G. & Voermans, R. P., 2021, In: Scandinavian Journal of Gastroenterology. 56, 5, p. 585-587 3 p.
Research output: Contribution to journal › Article › Academic › peer-review
Adjuvant chemotherapy is superior to chemoradiation after D2 surgery for gastric cancer in the per-protocol analysis of the randomized CRITICS trial
CRITICS investigators, Mar 2021, In: Annals of Oncology. 32, 3, p. 360-367 8 p.
Research output: Contribution to journal › Article › Academic › peer-review
Afucosylated igg targets fcγriv for enhanced tumor therapy in mice
Braster, R., Bögels, M., Benonisson, H., Wuhrer, M., Plomp, R., Bentlage, A. E. H., Korthouwer, R., Visser, R., Sjef Verbeek, J., van Egmond, M. & Vidarsson, G., 2 May 2021, In: Cancers. 13, 10, 2372.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

Immunoglobulin A as anti-cancer therapeutic antibodies 2.0?
Marjolein van Egmond (Speaker)
7 Feb 2020
Activity: Talk or presentation › Invited talk
Immunoglobulin A as anti-cancer therapeutic antibodies 2.0?
Marjolein van Egmond (Speaker)
2 Nov 2020 → 4 Nov 2020
Activity: Talk or presentation › Invited talk
Immunoglobulin A: Trojan horse or magic bullet?
Marjolein van Egmond (Speaker)
9 Jan 2020
Activity: Talk or presentation › Invited talk

Podcast Gezondheidsnet Het Corona Vaccin
Marjolein van Egmond
21/12/2020
1 Media contribution
Press/Media: Public Engagement Activities
Filmpje Universiteit van Nederland: Hoe gevaarlijk is het Corona vaccin?
Marjolein van Egmond
15/12/2020
1 Media contribution
Press/Media: Public Engagement Activities
NOS uitzending Corona virus: feiten en fabels.
Marjolein van Egmond
14/12/2020
1 Media contribution
Press/Media: Public Engagement Activities

Network